The demand for clinical trial services is growing fast. According to MarketsandMarkets, the global clinical trial services market was valued at $60.76 billion in 2024 and is expected to reach $101.86 billion by 2030. With so many CROs competing for your business, it is easy to feel overwhelmed during the selection process.
An experienced CRO can complete the trail in given time without inflating your budget, while choosing a wrong CRO can cause unnecessary delay, blowing your budget.
In this blog we will provide you key questions to ask before you sign any contract. Ask these questions to evaluate every clinical trial services company you speak with before finalising one.
Questions About Experience and Expertise
A. Therapeutic Area Experience
Some specialise in rare diseases, others in cardiovascular or metabolic conditions. If you are running oncology clinical trials services, for example, you need a CRO that has handled complex oncology protocols before, not one that is learning on the job.
Ask:
- Have you run trials in our specific disease area before?
- Can you share case studies or outcomes from similar studies?
- What is your success rate in trials like ours?
B. Phase-Specific Track Record
A CRO that is great at Phase I first-in-human studies may not have the scale to handle a global Phase III trial. Make sure the CRO has done it before at the phase you need.
- How many Phase I / II / III trials have you completed in the last five years?
- Do you have experience with first-in-human or rare disease trials?
C. Regulatory Track Record
- Have you worked with the FDA, EMA, or other regulatory bodies relevant to our trial?
- How many of your trials have led to successful regulatory submissions?
II. Questions About Capabilities and Infrastructure
A CRO may look good on paper but lack the actual infrastructure to deliver. Dig into the specifics.
A. Site Network and Patient Access
- How many investigator sites do you have in our target countries or regions?
- How do you qualify for new sites when your existing network does not cover a region?
Example: If you need to recruit 500 patients across Southeast Asia and the CRO has only 10 sites there, that is a serious mismatch.
B. Technology and Data Management
- What EDC, CTMS, and eClinical systems do you use?
- How do you ensure data integrity and provide real-time reporting to sponsors?
- Do you support decentralised or hybrid trial models?
C. Staffing and Capacity
- How many active trials are you currently running?
- Do you have in-country staff in the regions we need?
III. Questions About Compliance and Quality
A. Regulatory Compliance
- How do you ensure GCP compliance across all sites?
- How often are your SOPs reviewed and updated?
B. Audit History
- Have you received any FDA warning letters or EMA findings in the past three years?
- Can you share your most recent audit results?
Example: A CRO that has received multiple FDA warning letters is a risk to your submission timeline, even if their pricing is attractive.
C. Quality Assurance Process
- What does your internal QA monitoring look like?
- How do you handle protocol deviations and corrective action plans (CAPAs)?
IV. Questions About Project Management and Communication
Poor communication is one of the top reasons clinical trials fall behind. Before you commit, understand exactly how the CRO will keep you informed.
- Who will be our dedicated point of contact throughout the trial?
- How frequently will we receive progress updates and milestone reports?
- What is your escalation process when something goes wrong?
- Can you share an example of a trial that hit a setback and how you handled it?
V. Questions About Patient Recruitment and Retention
Patient recruitment is the most common reason trials fall behind schedule. According to Collective Minds Health, nearly three out of every four clinical trials are conducted by CROs, making site access and patient recruitment a core competency you should not overlook.
- What is your average patient recruitment rate vs. your projected timelines?
- How do you handle slow enrollment at underperforming sites?
- What patient retention strategies do you use?
- Can you recruit diverse or hard-to-reach patient populations?
VI. Questions About Contracts, Costs, and Flexibility
Cost is important, but a cheap CRO that goes over budget is not actually cheap. Ask these questions upfront to avoid surprises later.
A. Pricing and Budget
- Is your pricing model milestone-based, time-and-materials, or a fixed fee?
- How do you handle budget overruns and change orders?
Example: A fixed-fee model gives you cost certainty. A time-and-materials model can balloon if the trial takes longer than expected.
B. Contract Terms
- What are the termination clauses and exit conditions?
- How is intellectual property and data ownership defined in your agreements?
C. Flexibility and Scalability
- Can your services scale if our trial scope changes mid-study?
- Do you offer an FSP (Functional Service Provider) model if we only need partial support?
VII. Questions About Technology and Innovation
Technology is now a core part of clinical trials research services. A CRO that still relies on manual processes will slow you down. Ask about their tech stack, not just their people.
- Are you using AI or machine learning for data analysis, patient recruitment, or risk monitoring?
- What is your data security protocol? Are you GDPR and HIPAA compliant?
- How do you use real-world data or real-world evidence in your trial design?
Best Clinical Trial Services in India
If you are a pharma or medical device company in a need of clinical trail services, you should contact us at Innovate Research. Our team covers everything from phase 1 (First-in-Human) to phase 4 (Post-Marketing Surveillance).
Our team prioritises scientific rigor, patient safety, and full compliance with ICH-GCP, CDSCO regulations, and international ethical standards. Also, we will be happy to answer all the questions mentioned above.
Final Thoughts
Choosing a CRO is not a simple process. You need to develop a strategic partnership with them which will shape the outcome of your drug development programme. The right clinical trial services company will act like an extension of your own team, not just a service provider for ticking boxes.
Use the questions in this guide as your starting checklist. The answers will tell you a lot about how a CRO thinks, how they communicate, and whether they are ready to take on your studies.
Along with clinical trial services, our other services include medical writing, regulatory services, clinical monitoring, biospecimen collection, clinical data management and more. Visit Innovate Research to learn more about their services.
FAQs
- What should I ask a CRO before outsourcing a clinical trial?
You should ask about therapeutic area experience, phase-specific expertise, regulatory track record, site network, patient recruitment strategy, data management systems, quality processes, pricing model, and communication structure.
- Why is CRO experience in my therapeutic area important?
Therapeutic area experience helps ensure the CRO understands disease-specific protocols, patient recruitment challenges, safety requirements, endpoint complexities, and regulatory expectations relevant to your study.
- How do I evaluate a CRO’s regulatory compliance?
Ask whether the CRO follows ICH-GCP, local regulatory requirements, and international ethical standards. You should also review their SOPs, audit history, CAPA process, and experience with agencies such as FDA, EMA, or CDSCO. - What role does patient recruitment play in CRO selection?
Patient recruitment is one of the biggest factors affecting clinical trial timelines. A CRO should have a strong site network, realistic enrolment projections, retention strategies, and experience recruiting diverse or hard-to-reach patient groups.
- What makes Innovate Research a suitable clinical trial services partner in India?Innovate Research supports clinical trial services across Phase I to Phase IV, with a focus on scientific rigour, patient safety, ICH-GCP compliance, CDSCO regulations, clinical monitoring, data management, medical writing, and regulatory services.